Labverity
Facility profile

SUMITOMO OSAKA CEMENT CO., LTD.

Active pharmaceutical ingredient (API) manufacturing · OSAKA 597-0093 · Japan

FDA recordFDA directory updated Jul 21, 2026Profile not yet claimed2 registered company locations
Potential fit

Listed operations

The U.S. Food and Drug Administration (FDA) record lists broad activities for this site. Confirm specific services and availability directly.

Active pharmaceutical ingredient (API) manufacture
Due diligence

Regulatory record at a glance

Use these records to guide qualification; they are not a facility score.

Registration record
Current FDA registration record

Expires Dec 31, 2026 · checked Jul 21, 2026

Latest matched inspection
Voluntary action indicated (VAI)

Oct 27, 2023 · FDA documented observations for voluntary correction.

Matched compliance actions
None in our records

No warning letter, injunction, or seizure matched.

Understand this record

Use the evidence, then ask for fit.

Shows

Registration status and a latest matched voluntary action indicated inspection.

Doesn’t show

Exact services, availability, capacity, pricing, or overall quality.

Ask next

Ask what was corrected and review any later inspection or follow-up record.

Method and source details
View full inspection and compliance history2 inspection records

FDA inspection history

2 records, Jun 2017 – Oct 2023 · 0 NAI · 2 VAI · 0 OAI

DateClassProject areaCitationsFY
Oct 27, 2023VAIDrug Quality Assurance2024
Jun 29, 2017VAIDrug Quality AssuranceYes2017

No action indicated (NAI) · Voluntary action indicated (VAI) · Official action indicated (OAI)

Matched compliance actions

No warning letter, injunction, or seizure is matched in the current data set.

Unclaimed profile

Service details not yet provided

Methods, equipment, quality scope, capacity, turnaround, and commercial contacts are not available.

Ask about services